One rainy summer day, while waiting for my mom’s checkup at the Dana Farber Cancer Institute to finish, I snapped this picture. Just around the corner, the old building of the Joslin Diabetes Center is being demolished, to make room for a brand new cancer center run by Dana Farber. “Building the Future of Cancer Care”, as it says.
As a biopharma guy by trade, this felt extra poignant. Diabetes, that old intractable scourge, has finally been swept away by the GLP-1 revolution – that is, Ozempic, Moujaro, etc. – and with it, all the medical infrastructure required to manage it. Joslin continues to operate out of another building in the area, but when weight loss comes in the form of a simple pill/injection, how many people will still continue to need that level of care? And from there, what about all the other weight loss products, or even beyond that, everything that relates to obesity? In my field, I’ve heard of surgical equipment companies preparing for less use of their equipment, due to forecasting significantly fewer bariatric & gastrointestinal surgeries. From others, I’ve heard stories of fashion designers planning around average clothing sizes dropping, and restaurants around customers spending less at the table in the years to come.
Yes, I suppose, better to use that space for something that we can’t properly treat yet, like cancer. Hopefully, its day will come too in the near future.
Taken with a Contax RX and 50/1.4 Planar T*, on Ferrania P30 film.
Share this post:
Comments
Jeff T. on The Future of Care – A One Shot Story
Comment posted: 20/11/2026